Literature DB >> 25547954

French health insurance databases: What interest for medical research?

G Moulis1, M Lapeyre-Mestre2, A Palmaro3, G Pugnet4, J-L Montastruc5, L Sailler4.   

Abstract

French health insurance databases are organized since 2003 into a huge digital data warehouse, the Système national d'information inter-régime de l'assurance maladie (SNIIR-AM). It covers the entire French population (65 million inhabitants). In order to facilitate studies on more frequent conditions, a random sample of 1/97th of national health system beneficiaries has been built since 2005, called the échantillon généraliste des bénéficiaires (EGB). The aim of this article is to describe the main characteristics of the SNIIR-AM and the EGB, to detail their accessibility according to French law, and to present their strengths and limits. It is illustrated with the most recent studies conducted in these databases. These databases include demographic, out-hospital reimbursement (including drug dispensing), medical (costly long-term diseases, occupational diseases, sick-leaves…), and in-hospital data. All these data are prospectively recorded, individualized, made anonymous and linkable. Consequently, the SNIIR-AM is a very useful data source for epidemiological, pharmacoepidemiological and health economics studies, particularly for rare diseases. The EGB is appropriate for long-term research on more frequent diseases.
Copyright © 2014 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Assurance maladie; Base de données médico-administrative; France; Health Insurance; Medico-administrative databases; Système national d’information inter-régime de l’assurance maladie; Échantillon généraliste des bénéficiaires

Mesh:

Year:  2014        PMID: 25547954     DOI: 10.1016/j.revmed.2014.11.009

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  73 in total

1.  Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin's lymphoma: a cohort study of the French national health insurance database.

Authors:  Cécile Conte; Manuela Rueter; Guy Laurent; Robert Bourrel; Maryse Lapeyre-Mestre; Fabien Despas
Journal:  Support Care Cancer       Date:  2016-07-19       Impact factor: 3.603

2.  Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors:  Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

3.  Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital.

Authors:  Margaux Lafaurie; Liselotte Pochard; Clémence Lotiron; Laurent Molinier; Maryse Lapeyre-Mestre; Emilie Jouanjus
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

4.  Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.

Authors:  Patrick Blin; Caroline Dureau-Pournin; Régis Lassalle; Jérémy Jové; Florence Thomas-Delecourt; Cécile Droz-Perroteau; Nicolas Danchin; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2017-05-05       Impact factor: 4.335

5.  Readmissions After Bariatric Surgery in France, 2013-2016: a Nationwide Study on Administrative Data.

Authors:  Andrea Lazzati; Gilles Chatellier; Sandrine Katsahian
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

6.  Usage patterns of paracetamol in France.

Authors:  Mai Duong; Sinem Ezgi Gulmez; Francesco Salvo; Abdelilah Abouelfath; Régis Lassalle; Cécile Droz; Patrick Blin; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2016-05-18       Impact factor: 4.335

7.  Trajectories, bifurcations, and pseudo-time in large clinical datasets: applications to myocardial infarction and diabetes data.

Authors:  Sergey E Golovenkin; Jonathan Bac; Alexander Chervov; Evgeny M Mirkes; Yuliya V Orlova; Emmanuel Barillot; Alexander N Gorban; Andrei Zinovyev
Journal:  Gigascience       Date:  2020-11-25       Impact factor: 6.524

8.  PURLs: Which combined OC to prescribe with CV safety in mind?

Authors:  Yee Lam; Catherine Coe; Anne Mounsey
Journal:  J Fam Pract       Date:  2017-07       Impact factor: 0.493

9.  Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.

Authors:  François Montastruc; Anne Bénard-Laribière; Pernelle Noize; Elodie Pambrun; Fabienne Diaz-Bazin; Marie Tournier; Bernard Bégaud; Antoine Pariente
Journal:  Eur J Clin Pharmacol       Date:  2018-01-06       Impact factor: 2.953

10.  Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.

Authors:  Julie Dupouy; Aurore Palmaro; Mélina Fatséas; Marc Auriacombe; Joëlle Micallef; Stéphane Oustric; Maryse Lapeyre-Mestre
Journal:  Ann Fam Med       Date:  2017-07       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.